UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Diabetologia, ISSN 0012-186X, 1/2019, Volume 62, Issue 1, pp. 78 - 86
Cohort analysis | Macrophage inhibitory cytokine-1 | Medicine & Public Health | Human Physiology | Growth differentiation factor 15 | Diabetes mellitus | Metabolic Diseases | Internal Medicine | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fasting | Age Factors | Humans | Middle Aged | Diabetes Mellitus - metabolism | Male | Incidence | Obesity - metabolism | Hyperglycemia - metabolism | Waist Circumference - physiology | Diabetes Mellitus - epidemiology | Obesity - epidemiology | Sex Factors | Female | Blood Pressure - physiology | Hyperglycemia - epidemiology | Growth Differentiation Factor 15 - metabolism | Cohort Studies | Hyperglycemia | C-reactive protein | Growth | Analysis | Bone morphogenetic proteins | Diabetes | Cancer | Sensitivity analysis | Diet | Transforming growth factor | Inflammation | Index Medicus | Hälsovetenskap | Medical and Health Sciences | Medicin och hälsovetenskap | Public Health, Global Health, Social Medicine and Epidemiology | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Klinisk medicin | Clinical Medicine | Endokrinologi och diabetes | Endocrinology and Diabetes | Health Sciences
Journal Article
2.
Full Text
Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
The Journal of cell biology, ISSN 0021-9525, 2017, Volume 216, Issue 1, pp. 149 - 165
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Transcription Factor CHOP - genetics | Mitochondria, Liver - metabolism | Mitochondria, Muscle - metabolism | Homeostasis | Male | Muscle, Skeletal - metabolism | Obesity - genetics | Growth Differentiation Factor 15 - genetics | Adipose Tissue - metabolism | Transfection | Liver - drug effects | RNA Interference | Time Factors | Muscle, Skeletal - drug effects | Cell Cycle Proteins - genetics | Weight Gain | Genetic Predisposition to Disease | Oxidation-Reduction | Signal Transduction | Liver - metabolism | Mice, Inbred C57BL | Insulin Resistance | Oxidative Phosphorylation | Cell Cycle Proteins - deficiency | Leptin - genetics | Growth Differentiation Factor 15 - deficiency | Recombinant Proteins - pharmacology | 3T3-L1 Cells | Unfolded Protein Response | Lipolysis | Mice, Knockout | Obesity - metabolism | Phenotype | Animals | Obesity - prevention & control | Mice, Obese | Growth Differentiation Factor 15 - pharmacology | Mice | Growth Differentiation Factor 15 - metabolism | Leptin - deficiency | Transcription Factor CHOP - metabolism | Adipose Tissue - drug effects | Energy Metabolism - drug effects | Muscles | Physiological aspects | Insulin resistance | Growth | Proteins | Mitochondria | Cellular biology | Bioenergetics | Stress response | Index Medicus | 41 | s | 29
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 06/2019, Volume 198, pp. 46 - 58
Obesity | Energy metabolism | Growth differentiation factor 15 | Aging | Non-steroidal anti-inflammatory drug activated gene-1 | Cancer prevention | GFRAL receptor complex | Appetite suppression | Survival | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Neoplasms - metabolism | Animals | Body Weight | Metabolic Diseases - metabolism | Humans | Receptors, Cytokine - metabolism | Growth Differentiation Factor 15 - metabolism | Prevention | Physiological aspects | Health aspects | Body weight | Cancer | Index Medicus | appetite suppression | non-steroidal anti-inflammatory drug activated gene-1 | cancer prevention | survival | aging | Growth Differentiation Factor 15 | obesity | energy metabolism
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 11/2017, Volume 66, Issue 11, pp. 2774 - 2788
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Blood Glucose - physiology | Interleukin-13 - physiology | Th2 Cells - physiology | Interleukin-33 - pharmacology | Janus Kinases - metabolism | STAT6 Transcription Factor - genetics | Glucose Intolerance | Growth Differentiation Factor 15 - genetics | Interleukin-13 - genetics | RNA Interference | Diet, High-Fat | Interleukin-4 - genetics | Interleukin-4 - physiology | Janus Kinases - genetics | Interleukin-4 - metabolism | Receptors, Cell Surface - metabolism | Recombinant Proteins - pharmacology | STAT6 Transcription Factor - metabolism | 3T3-L1 Cells | Interleukin-13 - metabolism | Protein Disulfide Reductase (Glutathione) | Mice, Knockout | Animals | Glucose - metabolism | Mice | Mice, Inbred BALB C | Growth Differentiation Factor 15 - metabolism | Interleukin-33 - administration & dosage | Receptors, Cell Surface - genetics | Medical research | Obesity | Data analysis | Animal models | Adipose tissue | Cytokines | Homeostasis | Data processing | Lymphocytes T | Interleukin 13 | Glucose | Adipocytes | Ribonucleic acid--RNA | Insulin | High fat diet | Glucose tolerance | Glucose metabolism | Intolerance | Interleukin 4 | Stat6 protein | Janus kinase | Lipid metabolism | Galactosylceramide | Index Medicus | Abridged Index Medicus
Journal Article
Journal of cellular physiology, ISSN 0021-9541, 07/2010, Volume 224, Issue 1, pp. 120 - 126
Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Phosphorylation | Age Factors | Rats, Wistar | Apoptosis - drug effects | Transforming Growth Factor beta1 - metabolism | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Cardiomegaly - pathology | Male | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Ventricular Remodeling | Time Factors | Smad1 Protein - genetics | Nitric Oxide Donors - pharmacology | Angiotensin II - metabolism | Cells, Cultured | Rats | Myocytes, Cardiac - pathology | Oligonucleotides - metabolism | Animals | Cardiomegaly - prevention & control | Myocytes, Cardiac - drug effects | Signal Transduction - drug effects | Myocytes, Cardiac - metabolism | Smad1 Protein - metabolism | Protein Kinase Inhibitors - pharmacology | Growth Differentiation Factor 15 - metabolism | Cardiomegaly - metabolism | Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 02/2017, Volume 40, Issue 2, pp. 280 - 283
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Metformin - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Insulin Glargine - therapeutic use | Logistic Models | Biomarkers - blood | Dose-Response Relationship, Drug | Hypoglycemic Agents - blood | Insulin Glargine - blood | Growth Differentiation Factor 15 - blood | Polymorphism, Single Nucleotide | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Metformin - blood | Dosage and administration | Metformin | Blood sugar | Health aspects | Biomarkers | Glucose | Diabetes | Drug dosages | Index Medicus
Journal Article
Haematologica (Roma), ISSN 0390-6078, 03/2013, Volume 98, Issue 3, pp. 444 - 447
Life Sciences & Biomedicine | Hematology | Science & Technology | Hepcidins - metabolism | Liver - metabolism | RNA, Messenger - genetics | Phlebotomy | Homeostasis | Erythrocyte Indices | Male | RNA, Messenger - metabolism | Iron - metabolism | Growth Differentiation Factor 15 - genetics | Mice, Knockout | Animals | Spleen - metabolism | Bone Marrow - metabolism | Hepcidins - genetics | Female | Mice | Growth Differentiation Factor 15 - metabolism | Iron - blood | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 10, pp. 16972 - 16987
Hepatocellular carcinoma | Tumorigenesis | Metastasis | Cancer stem cells | GDF15 | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Immunohistochemistry | Humans | Middle Aged | Spheroids, Cellular - pathology | Male | Transplantation, Heterologous | Growth Differentiation Factor 15 - genetics | Neoplasm Metastasis | Neoplastic Stem Cells - metabolism | RNA Interference | Carcinoma, Hepatocellular - genetics | Neoplastic Stem Cells - pathology | Female | Liver Neoplasms - pathology | Chromones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Liver Neoplasms - genetics | Spheroids, Cellular - metabolism | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Mice, SCID | Glycogen Synthase Kinase 3 beta - metabolism | beta Catenin - metabolism | Blotting, Western | Animals | Signal Transduction - drug effects | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Cell Line, Tumor | Mice, Inbred NOD | Cell Proliferation - drug effects | Growth Differentiation Factor 15 - metabolism | Carcinoma, Hepatocellular - metabolism | Index Medicus
Journal Article
9.
Full Text
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Nature medicine, ISSN 1078-8956, 10/2017, Volume 23, Issue 10, pp. 1158 - 1166
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Surface Plasmon Resonance | Humans | Glial Cell Line-Derived Neurotrophic Factor Receptors - drug effects | Glial Cell Line-Derived Neurotrophic Factor Receptors - metabolism | Rats | Weight Loss - drug effects | Eating - genetics | Glial Cell Line-Derived Neurotrophic Factor Receptors - genetics | Rats, Sprague-Dawley | Mice, Knockout | Obesity - metabolism | Eating - drug effects | Animals | Flow Cytometry | HEK293 Cells | Growth Differentiation Factor 15 - pharmacology | Mice | Energy Metabolism - genetics | In Vitro Techniques | Weight Loss - genetics | Energy Metabolism - drug effects | Obesity | Care and treatment | Genetic aspects | Gene expression | Health aspects | Glial cell line-derived neurotrophic factor | Neurons | Body weight | Energy expenditure | Intracellular signalling | Food intake | Rodents | Animal tissues | Minimum inhibitory concentration | Weight reduction | Hindbrain | Ligands | Food | Index Medicus
Journal Article